| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.34 | 0.007 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |